Editor: Sarah A team of researchers from Shandong University has developed a new drug delivery system that could improve the treatment of Triple-Negative Breast Cancer (TNBC), one of the most…
Editor: Tiffany Researchers have developed an ionizable lipid nanoparticle (LNP) platform to deliver TRAIL mRNA directly to the tumor microenvironment, effectively inducing tumor cell death and inhibiting colon cancer progression,…
Editor: Nina Scientists develop a self-augmented ROS-responsive polymeric nanocarrier for synergistic chemoimmunotherapy that co-delivers paclitaxel and 1-methyl-D,L-tryptophan to enhance anti-tumor efficacy and modulate the immunosuppressive tumor microenvironmen. Key Preview Introduction…
Editor: Tiffany A study published in Scientific Reports demonstrates that evodiamine-loaded bovine serum albumin nanoparticles enhance the compound’s anticancer activity against breast cancer cells by improving solubility and targeted delivery.…
Editor: Nina Scientists develop pH-gated nanoparticles that selectively reprogram tumor-associated macrophages to enhance anti-tumor immune responses, offering a novel strategy for targeted cancer immunotherapy. Key Preview Introduction Cancer remains one…
Editor: Tiffany Researchers at the University of Pennsylvania have developed a high-throughput barcoding technology that successfully identifies lipid nanoparticles for effective mRNA delivery to lung tissues, potentially improving treatments for…
Editor: Nina Scientists develop a multifunctional nanoparticle system that selectively depletes NADPH in tumor cells while enhancing anti-PD-L1 therapy and reprogramming the tumor microenvironment to improve treatment outcomes for triple-negative…
Editor: Tiffany A new study demonstrates that engineered macrophages with preserved membrane structures can neutralize multiple inflammatory cytokines, showing promise in animal models of rheumatoid arthritis and acute pneumonia. Key…